E
Elliott M. Antman
Researcher at Brigham and Women's Hospital
Publications - 738
Citations - 187175
Elliott M. Antman is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Myocardial infarction & TIMI. The author has an hindex of 161, co-authored 716 publications receiving 179462 citations. Previous affiliations of Elliott M. Antman include Duke University & Katholieke Universiteit Leuven.
Papers
More filters
Journal ArticleDOI
Experimental and clinical observations on the efficacy of esmolol in myocardial ischemia
Robert A. Kloner,Robert A. Kloner,James M. Kirshenbaum,James M. Kirshenbaum,Rudiger Lange,Rudiger Lange,Elliott M. Antman,Elliott M. Antman,Eugene Braunwald,Eugene Braunwald +9 more
TL;DR: Esmolol's brief duration of action may make it safer than conventional beta blockers for the management of patients with unstable angina or myocardial infarction and may be useful in patients with ischemic heart disease.
Journal ArticleDOI
Comparison of enoxaparin versus unfractionated heparin in patients with unstable angina pectoris/non-ST-segment elevation acute myocardial infarction having subsequent percutaneous coronary intervention.
TL;DR: Treatment with enoxaparin was beneficial and well tolerated in patients with unstable angina and non-ST-segment elevation MI who underwent percutaneous coronary intervention, and exhibited a similar risk of major hemorrhage to UFH in patients who underwent PCI.
Journal ArticleDOI
ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to update the 2001 Guidelines for Percutaneous Coronary Intervention).
Sidney C. Smith,Ted Feldman,John W. Hirshfeld,Alice K. Jacobs,Morton J. Kern,Spencer B. King,Douglass A. Morrison,William W. O'Neill,Hartzell V. Schaff,Patrick L. Whitlow,David O. Williams,Elliott M. Antman,Cynthia D. Adams,Jeffrey L. Anderson,David P. Faxon,Valentin Fuster,Jonathan L. Halperin,Loren F. Hiratzka,Sharon A. Hunt,Rick A. Nishimura,Joseph P. Ornato,Richard L. Page,Barbara Riegel +22 more
TL;DR: The American College of Cardiology/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention (PCI) contains changes in the recommendations, along with supporting text.
Journal ArticleDOI
Prasugrel Versus Clopidogrel in Patients With ST-Segment Elevation Myocardial Infarction According to Timing of Percutaneous Coronary Intervention : A TRITON–TIMI 38 Subgroup Analysis (Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel–Thrombolysis In Myocardial Infarction 38)
Jacob A. Udell,Eugene Braunwald,Elliott M. Antman,Sabina A. Murphy,Gilles Montalescot,Stephen D. Wiviott +5 more
TL;DR: The efficacy of prasugrel versus clopidogrel was consistent irrespective of the timing of PCI, particularly in preventing nonprocedural events.
Journal ArticleDOI
Transition of patients from blinded study drug to open-label anticoagulation: the ENGAGE AF-TIMI 48 trial.
Christian T. Ruff,Robert P. Giugliano,Eugene Braunwald,Michele Mercuri,Valentin Curt,Joshua Betcher,Laura T. Grip,Abby Cange,Andrea E. Crompton,Sabina A. Murphy,Naveen Deenadayalu,Elliott M. Antman +11 more
TL;DR: The ENGAGE AF-TIMI 48 transition plan protected patients from an excess of thrombotic and bleeding events and should be helpful in clinical practice when patients are transitioned between oral anticoagulants.